Published on in Vol 4, No 2 (2021): Jul-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/27869, first published
.
Journals
- Mora Hurtado A, Endo J. Lack of skin of color reporting in disease severity rating tools used for inflammatory skin conditions: A scoping review. Journal of the American Academy of Dermatology 2024;90(2):432 View
- Pathak G, Chandy R, Naini V, Feldman S, Rao B, Vassileva S. Quality of Life Assessments Utilized in Vitiligo Clinical Trials. Dermatologic Therapy 2023;2023(1) View
- Eshmawi M, Yousef Al-Mudaiheem H, Fatani M, Binamer Y, Alajlan M, Alharithy R, Alotaibi H, Almohanna H, Alsantali A, Madani A, Al-Faraidy N, Bechara F, H. Al-Jedai A. Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia. Journal of Dermatological Treatment 2024;35(1) View
- Pathak G, Patel K, Wachuku C, Truong T, Agarwal P, Rao B. Trends in disease severity and quality of life outcome measures in pemphigus clinical trials: A scoping review. Skin Health and Disease 2024;4(5) View
- De D, Baskaran N, Thakur V, Hanumanthu V, Bakshi S, Bhandari S, Katoch D, Handa S. A Clinicodemographic Study of Indian Patients with Hidradenitis Suppurativa and its Association with Metabolic Syndrome. Indian Dermatology Online Journal 2024 View
- Park S, Hsiao J, Aleshin M. Innovations in Hidradenitis Suppurativa. Dermatologic Clinics 2025;43(1):35 View